Delivery Order 75N93021D00004-75N93021F00001

Award Date 10/15/20
Potential Completion Date 5/14/21
Potential Value Not listed
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This task order was awarded to Research Triangle Institute, doing business as RTI International, as the prime contractor. RTI will develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting in support of the Preclinical Services for HIV Therapeutics program, a $17,299 cost-plus-fixed-fee delivery order issued by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The work is being performed under the...
This task order, awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Southern Research Institute, funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract vehicle. The purpose of this delivery order is to provide preclinical services in support of HIV therapeutics research and development efforts. With a potential value of $0.00 and cost-no-fee pricing, this task...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to the Research Triangle Institute (RTI International), a non-profit research organization. The $334,662 cost-plus-fixed-fee contract is for conducting confirmatory and specialized in vitro testing and screening of interventional agents related to human immunodeficiency virus (HIV) therapeutics. The work is performed under the agency's...
This is a $227,601 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Preclinical Services for HIV Therapeutics Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The purpose is to conduct in vitro screening of interventional agents in high throughput screening (HTS) formats to identify HIV inhibitors. The prime contractor is Research Triangle Institute (RTI International), a non-profit research organization. Two subcontractors are...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $0 delivery order against the Preclinical Services for HIV Therapeutics master IDIQ contract to the University of North Carolina at Chapel Hill Office of Sponsored Research. The purpose of this task order is to fund the guaranteed minimum amount of the contract to provide preclinical services in support of developing HIV therapeutics. Performance will take...
This task order funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract vehicle held by Sri International. The National Institute of Allergy and Infectious Diseases, a component of the Department of Health and Human Services' National Institutes of Health, awarded this $0 delivery order against the multiple award indefinite delivery/indefinite quantity master contract. Sri International will perform preclinical services in West Menlo Park, California in...
This task order, awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases, funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract held by The University of Iowa. The purpose of this $0.00 delivery order is to provide preclinical services in support of developing therapeutics to treat HIV/AIDS. Set to be completed by May 2021, this award draws from the potential $0...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $544,842 delivery order contract to Research Triangle Institute - doing business as R T I International. The contract is being performed under the prime contractor's master indefinite-delivery/indefinite-quantity contract for Nonclinical Services for Development of Interventional Agents. Work will involve nonclinical services to support the development of...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Research Triangle Institute (RTI International), a prominent non-profit research organization. The $1,480,550.00 cost-plus-fixed-fee contract is for the development and testing of HIV assays to identify targeted activators of cell kill molecules. The contract is a Delivery Order under the Preclinical Services for HIV Therapeutics...
This task order funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract vehicle with the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The $0 potential value indicates the order is funding pre-established contract capacity rather than discrete services. Alchem Laboratories Corporation will perform the preclinical services as the prime contractor, with place of performance in Alachua, Florida. No set-aside...

This task order funds the guaranteed minimum amount under the prime contract between Research Triangle Institute (RTI) International and the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose is to support preclinical services for HIV therapeutics research under the larger Preclinical Services for HIV Therapeutics master IDIQ contract vehicle. With a potential value of $0.00, this delivery order was awarded on October 15, 2020 to RTI International as the prime contractor. Performance will take place in Research Triangle Park, North Carolina through May 14, 2021. No set-aside designation was used for this award to fund preclinical research services towards the development of treatments for HIV/AIDS.

Generated 1/3/24, 1:49 PM